Insilico Medicine and SK Biopharmaceuticals achieved AI-powered drug discovery collaboration worth up to 2.5 billion for neuroimmune disorders
Business Announcement
Updates every hour. Last Updated: 22-Jun-2026 20:15 ET (23-Jun-2026 00:15 GMT/UTC)
Insilico Medicine ("Insilico", 3696.HK), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, and SK Biopharmaceuticals, a Korean-based company leads the way in biotech innovation with groundbreaking drug research, development, and commercialization worldwide, announced a research and development collaboration at the BIO 2026 International Convention to discover AI-enabled innovative drug candidates in the neuroimmune area of the central nervous system (CNS).
WASHINGTON, D.C. — SfN member Amy Arnsten, PhD, Albert E. Kent professor of Neuroscience and Psychology at Yale University School of Medicine, is the recipient of the Peter Seeburg Integrative Neuroscience Prize 2026. Arnsten is recognized for her foundational work in understanding the distinctive molecular, cellular, and circuit mechanisms that underlie executive brain functions. Her work has transformed understanding of how recently evolved prefrontal cortical circuits support working memory, abstract thought, and goal-directed behavior, and how these circuits are dynamically regulated by neuromodulatory systems and vulnerable to disruption by stress, aging, and disease.
A team of researchers has developed a new type of imaging sensor that uses both light and sound to create detailed pictures of biological tissues. This marks the first successful use of an array of over 40 microscopic, polymer-based "microrings" to capture these types of images. It can track oxygen levels, blood flow, and how dense blood vessels are. Therefore, it is much more effective at spotting the early signs of cancer.
Paneth cell metaplasia (PCM), long viewed as a consequence of chronic inflammation in ulcerative colitis, may also help protect and repair the intestine, according to researchers at Science Tokyo. The study found that inflammation increases IL-22 signaling, which promotes PCM and the production of REG3A, a protein that helps heal the intestinal lining. The findings suggest PCM may be a protective response but should be monitored because persistent PCM could increase cancer risk.
A newly published correspondence in The Lancet Global Health challenges the reliability of a widely cited Gaza Mortality Survey. Based on a reanalysis of the survey's publicly released data, the authors identify interviewer-level anomalies, departures from the stated sampling methodology, and inconsistencies with external demographic data, arguing that these issues raise significant concerns about the survey's representativeness and the validity of its estimates of conflict-related deaths in Gaza.